Concepedia

Guillain-Barré syndrome following the first dose of Pfizer-BioNTech COVID-19 vaccine: case report and review of reported cases

Nadia Bouattour, Olfa Hdiji, Salma Sakka, Emna Fakhfakh, Khadija Sonda Moalla, Sawsan Daoud, Nouha Farhat, Mariem Damak, Chokri Mhiri

Neurological Sciences · 2021 · 33 citations · 12 references

DOIFull text

Open access

Concepts

References

12

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

Fernando P. Polack, Stephen J. Thomas, Nicholas Kitchin et al. · New England Journal of Medicine · 2020 · 15.1K citations · Full text

Diagnosis of Guillain-Barre syndrome and validation of Brighton criteria

C. Fokke, B. van den Berg, Judith Drenthen et al. · Brain · 2013 · 758 citations · Full text

Neurological Complications of COVID-19: Guillain-Barre Syndrome Following Pfizer COVID-19 Vaccine

Sadia Waheed, Angel Bayas, Fawzi Hindi et al. · Cureus · 2021 · 249 citations · Full text

Electrophysiological diagnosis of Guillain–Barré syndrome subtype: could a single study suffice?

Yusuf A. Rajabally, Marie‐Christine Durand, James Mitchell et al. · Journal of Neurology Neurosurgery & Psychiatry · 2014 · 205 citations

Guillain–Barré Syndrome Variant Occurring after <scp>SARS‐CoV‐2</scp> Vaccination

Christopher Allen, Shelby Ramsamy, Alexander W. Tarr et al. · Annals of Neurology · 2021 · 154 citations · Full text

, , +12